For our July 2026 Inspire2Live World Campus session, we welcomed Professor Andrew Biankin from the University of Glasgow, a leading clinician scientist in cancer research and precision medicine.

In his presentation, “Virtual Human Twins,” Andrew introduced the concept of creating a digital representation of an individual patient that can bring together different types of health and cancer data. By modelling a patient’s unique characteristics, disease and potential treatment responses, Virtual Human Twins could help researchers and clinicians better understand what might happen before making important treatment decisions.

Professor explored how this technology could support more personalised cancer treatment, allowing different treatment options to be investigated and potentially helping clinicians identify the approach most likely to benefit an individual patient. The ultimate ambition is to move beyond a one-size-fits-all approach and make cancer care increasingly predictive, personalised and precise.

This work is particularly important to Inspire2Live. Ilona, Richard and Peter are already working with Andrew through a Horizon Europe proposal on Virtual Human Twins, sharing the belief that this innovation can become a powerful tool for improving outcomes for people with cancer.

The ultimate goal is simple: use innovation and research to help every patient receive the right treatment at the right time.

Watch the full session to discover how Virtual Human Twins could shape the future of personalised cancer care: